Get started
Author

Huaijun Zhou

Efficacy and Safety of Benmelstobart Plus Anlotinib in Advanced Endometrial Cancer: Results of a Multi‐Cohort, Phase II Study (ETER200)
2026 · Shanhui Liang, Xiaojun Chen, et al. · MedComm
Updated Efficacy and Safety Data of First-line Anlotinib + Carboplatin/paclitaxel Induction Followed by Anlotinib Maintenance in Advanced Ovarian Cancer: Phase Ii Multicenter Trial (alter-go-010)
2026 · Wenjun Cheng, Yi Jiang, et al. · International Journal of Gynecological Cancer
Preliminary efficacy and safety of first-line anlotinib plus carboplatin/paclitaxel induction therapy followed by anlotinib maintenance in advanced ovarian cancer: Results from the ALTER-GO-010 phase II multicenter trial.
2026 · Wenjun Cheng, Yi Jiang, et al. · Journal of Clinical Oncology
Abstract 7654: Unique oncogenic mechanisms of ultrahigh-frequency mutant PTENR130Gin endometrial cancer.
2026 · Xiangyi Kong, Li Wang, et al. · Cancer Research
Works count: 4
Citation count:
H-index:
I10-index:
Year
Topic
Type